Danish Pain Research Center
28
1
1
26
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
3.6%
1 terminated/withdrawn out of 28 trials
96.3%
+9.8% vs industry average
25%
7 trials in Phase 3/4
4%
1 of 26 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (28)
Gabapentin in Phantom and Stump Pain
Role: lead
Exploring the Genetics of Neuropathic Pain
Role: collaborator
Neuropathic Pain After Lung Surgery
Role: lead
The Effect of Lacosamide in Peripheral Neuropathic Pain
Role: lead
Resistance Training in Patients With Diabetic Neuropathy
Role: lead
Neuropathic Pain After Breast Surgery
Role: lead
Chronic Neuropathy Following Chemotherapy
Role: lead
Identification of Neuromas by High Resolution Ultrasound in Patients With Peripheral Nerve Injury and Amputations
Role: lead
Neuromas as the Cause of Pain
Role: lead
Polyneuropathy in Diabetes Mellitus Type 2
Role: lead
Postamputation Pain: Peripheral Mechanisms
Role: lead
Autonomic Responses During the Valsalva Maneuver and Deep Breathing Test Depend on the Experimental Setup
Role: lead
Pain Processing in Anxiety and Depression
Role: lead
Ultramicronized PEA (Normast) in Spinal Cord Injury Neuropathic Pain
Role: lead
Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain
Role: collaborator
Treatment With Spinal Cord Stimulation: Effect on Sensory Parameters
Role: lead
Pain After Stroke, Part 2: Clinical Characteristics and Classification of Pain in Patients After Stroke
Role: lead
Central Post-Stroke Pain - a Prospective Study
Role: lead
Topical Lidocaine: Predictors of Response in Peripheral Nerve Injury
Role: lead
Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury
Role: lead